2012
DOI: 10.1016/s0959-8049(12)71781-1
|View full text |Cite
|
Sign up to set email alerts
|

1187 Molecular Mechanism of Synergistic Anti-tumor Activity by the Combination of Natural Compounds Green Tea (-)Epigallocathetin-3-gallate (EGCG) and Resveratrol for Potential Chemoprevention in Head and Neck Cancer (HNC)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…EGCG antagonizes toxicity induced by anti-cancer chemotherapeutic agents, and sensitizes chemo-resistant cancer cells. It also exerts synergistic effects with anti-cancer agents in various cancer cells, such as cisplatin, oxaliplatin, temozolomide, resveratrol, doxorubicin, vardenafil, curcumin, erlotinib [122][123][124][125][126][127][128][129]. EGCG can enhance the sensitivity of cisplatin through copper transporter 1 (CTR1) up-regulation, which results in the accumulation of cellular cisplatin and cisplatin-DNA adducts in human ovarian cancer SKOV3 and OVCAR3 cells, and the combination of EGCG and cisplatin suppresses tumor growth in OVCAR3 xenograft mice [122].…”
Section: Epigallocatechin Gallate (Egcg)mentioning
confidence: 99%
“…EGCG antagonizes toxicity induced by anti-cancer chemotherapeutic agents, and sensitizes chemo-resistant cancer cells. It also exerts synergistic effects with anti-cancer agents in various cancer cells, such as cisplatin, oxaliplatin, temozolomide, resveratrol, doxorubicin, vardenafil, curcumin, erlotinib [122][123][124][125][126][127][128][129]. EGCG can enhance the sensitivity of cisplatin through copper transporter 1 (CTR1) up-regulation, which results in the accumulation of cellular cisplatin and cisplatin-DNA adducts in human ovarian cancer SKOV3 and OVCAR3 cells, and the combination of EGCG and cisplatin suppresses tumor growth in OVCAR3 xenograft mice [122].…”
Section: Epigallocatechin Gallate (Egcg)mentioning
confidence: 99%
“…It is of industrial interest to develop the products that contain several bioactive components in the market, thus providing multiple health benefits. , Moreover, the synergistic effect was reported in the combination of different bioactive components. It is thus required to develop the carriers that can simultaneously encapsulate and protect different bioactive components. β-Lactoglobulin, which contains a primary binding site in the internal cavity and multiple external potential binding sites, was reported to bind α-tocopherol, resveratrol, and folic acid simultaneously to form protein-triligand complexes .…”
Section: Introductionmentioning
confidence: 99%
“…Combination therapy significantly improves effectiveness compared to the traditional single-drug, single-target treatment paradigm. It has been found that EGCG is able to sensitize chemotherapy-resistant cancer cells, and it can act synergistically with various anticancer drugs in cancer treatment, such as cisplatin, oxaliplatin, temozolomide, resveratrol, doxorubicin, vardenafil, curcumin, erlotinib, and others [ 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 ]. In human ovarian cancer SKOV3 and OVCAR3 cells, EGCG enhances sensitivity to cisplatin by upregulating copper transporter protein 1 (CTR1), leading to the accumulation of intracellular cisplatin and cisplatin-DNA adducts, and the combination of EGCG and cisplatin inhibits tumor growth in OVCAR3 xenograft mice [ 278 ].…”
Section: Synergistic Effects and Combination Therapiesmentioning
confidence: 99%